Patents by Inventor Bruno Guy

Bruno Guy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6379675
    Abstract: Immunological compositions and methods for making and using them. The compositions contain at least one antigen and at least one lipoprotein and optionally an adjuvant. The lipoprotein can itself be antigenic or immunogenic. The antigen can be influenza HA and the lipoprotein a recombinantly expressed product having an OspA leader for lipidation and PspA for the protein portion. The antigen can be OspC and the lipoprotein OspA. The components of the composition are co-administered. A potentiated immunological response is obtained by the compositions and methods.
    Type: Grant
    Filed: January 19, 1996
    Date of Patent: April 30, 2002
    Assignee: Connaught Laboratories, Inc.
    Inventors: Robert S. Becker, Robert C. Huebner, Maryann Gray, Karen S. Biscardi, Lorne F. Erdile, Bruno Guy
  • Patent number: 6326892
    Abstract: An electronic device for monitoring the cold chain of a product, which measures the temperature, carries out the product of the measured temperature by a determined coefficient depending on the temperature, successively adds the products and records the running total obtained, and which includes a visual control. The measuring of the temperature is carried out at regular time intervals.
    Type: Grant
    Filed: April 20, 2000
    Date of Patent: December 4, 2001
    Inventor: Bruno Guy Thierry De La Forterie
  • Patent number: 6126938
    Abstract: The invention relates to a pharmaceutical composition intended for inducing in a host mammal a protective immune response against an antigen, at a mucosal effector site, which comprises at least two identical or different products each containing an inducing agent for the immune response, selected from the antigen and, provided the antigen is protein in nature, an expression cassette capable of expressing the antigen, for a concomitant or consecutive administration; one of the products being formulated so as to be administered via the nasobuccal route so that the inducing agent is targeted to the inducer site(s) for an immune response in the naso-oropharynx or the salivary glands, the other product being formulated so as to be administered via a suitable mucosal route other than the nasal route, so that the inducing agent is targeted to the inducer site(s) for an immune response at the effector site at which the immune response is sought.
    Type: Grant
    Filed: February 4, 1998
    Date of Patent: October 3, 2000
    Assignee: Pasteur Merieux Serums & Vaccins
    Inventors: Bruno Guy, Jean Haensler, Marie-Jose Quentin-Millet